Community health worker for Pollution Exposure

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Pollution ExposureCommunity health worker - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test two different interventions to reduce exposure to harmful toxins in drinking water for people who use private wells. The study will determine which intervention is more effective in promoting behaviors that reduce exposure to contaminated well water.

Treatment Effectiveness

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: 6 and 12 months

12 months
Clean water sample
Treatment implemented by homeowner that will reduce their exposure to arsenic, nitrate or lead in their drinking water
6 and 12 months
Well Stewardship Behaviors
Month 12
Health history - Anemia
Health history - Blood pressure
Health history - Cancer
Health history - Cardiovascular
Health history - Diabetes
Health history - Reproductive Health
Health literacy
Patient-Reported Quality of life
Risk perception

Trial Safety

Trial Design

2 Treatment Groups

Arm 1: Usual practice
1 of 2
Arm 2: Health navigator
1 of 2

Active Control

Experimental Treatment

215 Total Participants · 2 Treatment Groups

Primary Treatment: Community health worker · No Placebo Group · N/A

Arm 2: Health navigator
Behavioral
Experimental Group · 1 Intervention: Community health worker · Intervention Types: Behavioral
Arm 1: Usual practice
Behavioral
ActiveComparator Group · 1 Intervention: Community health worker · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Community health worker
2015
N/A
~3510

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 and 12 months

Who is running the clinical trial?

National Institute of Environmental Health Sciences (NIEHS)NIH
267 Previous Clinical Trials
1,225,338 Total Patients Enrolled
Oregon State UniversityLead Sponsor
44 Previous Clinical Trials
8,150 Total Patients Enrolled
Oregon Health AuthorityUNKNOWN
3 Previous Clinical Trials
24,100 Total Patients Enrolled
Veronica Irvin, PhDPrincipal InvestigatorOregon State University
Molly Kile, ScDPrincipal InvestigatorOregon State University

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: